BioSign Flu A and B, Germaine Laboratories
Supplier: Germaine Laboratories
BSP-510-25
BSP-510-P
76143-706BX
603.57
USD
76143-706
76143-708
BioSign Flu A and B, Germaine Laboratories
Assays
Immunological Assays
An In vitro rapid qualitative test that detects influenza type A & type B antigens directly from nasal swab, nasopharyngeal swab, and nasal aspirate/wash specimens.
- Defferenciates between Inlfuenza Type A & B, on a sigle test device
- Get results in 10–15 minutes
- Each test device has built in controls
- Each kit comes with external controls
- Meets FDA preformance criteria for Influenza tests stated in code 21 CFR 866.3328
CLIA Complexity: Moderate complexity when used with Nasal Wash/Aspirate samples. CLIA Waived when used with nasal and nasopharyngeal swabs.
It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections, from the same specimen.
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...